Literature DB >> 24373168

OPTN/SRTR 2012 Annual Data Report: liver.

W R Kim1, J M Smith, M A Skeans, D P Schladt, M A Schnitzler, E B Edwards, A M Harper, J L Wainright, J J Snyder, A K Israni, B L Kasiske.   

Abstract

Liver transplant in the us remains a successful life-saving procedure for patients with irreversible liver disease. In 2012, 6256 adult liver transplants were performed, and more than 65,000 people were living with a transplanted liver. The number of adults who registered on the liver transplant waiting list decreased for the first time since 2002; 10,143 candidates were added, compared with 10,359 in 2011. However, the median waiting time for active wait-listed adult candidates increased, as did the number of candidates removed from the list because they were too sick to undergo transplant. The overall deceased donor transplant rate decreased to 42.3 per 100 patient-years, and varied geographically from 18.9 to 228.0 per 100 patient-years. Graft survival continues to improve, especially for donation after circulatory death livers. The number of new active pediatric candidates added to the waiting list also decreased. Almost 75% of pediatric candidates listed in 2009 underwent transplant within 3 years; the 2012 rate of deceased donor transplants among active pediatric wait-listed candidates was 136 per 100 patient-years. Graft survival for deceased donor pediatric transplants was 92.8% at 30 days. Medicare paid for some or all of the care for more than 30% of liver transplants in 2010. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Liver transplant; model for end-stage liver disease; waiting list

Mesh:

Substances:

Year:  2014        PMID: 24373168     DOI: 10.1111/ajt.12581

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  68 in total

Review 1.  Current and Future Burden of Chronic Nonmalignant Liver Disease.

Authors:  Prowpanga Udompap; Donghee Kim; W Ray Kim
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-17       Impact factor: 11.382

Review 2.  Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.

Authors:  Pratima Sharma; Khurram Bari
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

3.  New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases.

Authors:  Jennifer R Ferrer; Attasit Chokechanachaisakul; Jason A Wertheim
Journal:  Curr Transplant Rep       Date:  2015-06-01

4.  Von Willebrand factor and alkaline phosphatase predict re-transplantation-free survival after the first liver transplantation.

Authors:  Andreas Wannhoff; Conrad Rauber; Kilian Friedrich; Christian Rupp; Wolfgang Stremmel; Karl Heinz Weiss; Peter Schemmer; Daniel N Gotthardt
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

5.  Methods for Contrasting Gap Time Hazard Functions: Application to Repeat Liver Transplantation.

Authors:  Xu Shu; Douglas E Schaubel
Journal:  Stat Biosci       Date:  2016-09-26

Review 6.  What's new in clinical solid organ transplantation by 2013.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2014-12-24

7.  Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.

Authors:  Theodore H Welling; Kevin Eddinger; Kristen Carrier; Danting Zhu; Tyler Kleaveland; Derek E Moore; Douglas E Schaubel; Peter L Abt
Journal:  Liver Transpl       Date:  2018-09       Impact factor: 5.799

8.  Risk factors for new-onset chronic kidney disease in patients who have received a liver transplant.

Authors:  Yuehong Li; Binbin Li; Wei Wang; Jiaxuan Lv
Journal:  Exp Ther Med       Date:  2018-01-31       Impact factor: 2.447

9.  Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.

Authors:  Allison J Kwong; Jennifer C Lai; Jennifer L Dodge; John P Roberts
Journal:  Liver Transpl       Date:  2015-11       Impact factor: 5.799

10.  Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.

Authors:  Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Jihee L Suh; Ashish K Sharma; Helen P Cathro; Daniel G Maluf
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.